BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22334658)

  • 1. Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.
    Lagarde WH; Blackwelder AJ; Minges JT; Hnat AT; French FS; Wilson EM
    J Biol Chem; 2012 Mar; 287(14):10905-15. PubMed ID: 22334658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.
    Askew EB; Bai S; Blackwelder AJ; Wilson EM
    J Biol Chem; 2010 Jul; 285(28):21824-36. PubMed ID: 20448036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.
    Liu Q; Su S; Blackwelder AJ; Minges JT; Wilson EM
    J Biol Chem; 2011 Aug; 286(34):29951-63. PubMed ID: 21730049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.
    Askew EB; Bai S; Parris AB; Minges JT; Wilson EM
    Mol Cell Endocrinol; 2017 Mar; 443():42-51. PubMed ID: 28042025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
    Askew EB; Bai S; Hnat AT; Minges JT; Wilson EM
    J Biol Chem; 2009 Dec; 284(50):34793-808. PubMed ID: 19828458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mutation of the androgen receptor, P817A, causing partial androgen insensitivity syndrome: in vitro and structural analysis.
    Lumbroso S; Wagschal A; Bourguet W; Georget V; Mazen I; Servant N; Audran F; Sultan C; Auzou G
    J Mol Endocrinol; 2004 Jun; 32(3):679-87. PubMed ID: 15171708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
    Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
    J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor.
    Bai S; Wilson EM
    Mol Cell Biol; 2008 Mar; 28(6):1947-63. PubMed ID: 18212060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome.
    Holterhus PM; Brüggenwirth HT; Hiort O; Kleinkauf-Houcken A; Kruse K; Sinnecker GH; Brinkmann AO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3584-9. PubMed ID: 9360511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
    De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
    Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.